Full text is available at the source.
Abstract
IL-4 MSCs within macroporous gelatin-based scaffolds enhanced bone formation in mice with critical-size long bone defects.
- IL-4 MSCs increased the expression of M2 markers, indicating a shift towards tissue regeneration.
- M1 marker expression was not inhibited during the early phase, suggesting a balanced immune response.
- Enhanced macrophage migration into the scaffold was observed, which may support healing.
- Bone formation was significantly improved six weeks after treatment with IL-4 MSCs.
- IL-4 MSCs may provide a promising approach for treating critical-size long bone defects.
Simplified